Cedars-Sinai Medical Center

UT Health San Antonio secures $16.4 million from CPRIT over six months, adding transformative expertise, bolstering cancer research

Retrieved on: 
Friday, March 8, 2024

SAN ANTONIO, March 7, 2024 /PRNewswire-PRWeb/ -- The University of Texas Health Science Center at San Antonio (UT Health San Antonio) (https://uthscsa.edu/) has secured approximately $16.4 million in funding from the Cancer Prevention and Research Institute of Texas (https://www.cprit.state.tx.us/about-us) the past six months, attracting three top cancer researchers and advancing child and adolescent cancer research.

Key Points: 
  • SAN ANTONIO, March 7, 2024 /PRNewswire-PRWeb/ -- The University of Texas Health Science Center at San Antonio (UT Health San Antonio) ( https://uthscsa.edu/ ) has secured approximately $16.4 million in funding from the Cancer Prevention and Research Institute of Texas ( https://www.cprit.state.tx.us/about-us ) the past six months, attracting three top cancer researchers and advancing child and adolescent cancer research.
  • The Mays Cancer Center at UT Health San Antonio ( https://cancer.uthscsa.edu/ ) is one of only four National Cancer Institute-designated Cancer Centers in Texas.
  • The Mays Cancer Center provides leading-edge cancer care, propels innovative cancer research and educates the next generation of leaders to end cancer in South Texas.
  • The Greehey Children's Cancer Research Institute ( https://cancer.uthscsa.edu/gccri ) is one of only two institutes in the United States dedicated solely to pediatric cancer research.

The Angelman Syndrome Foundation (ASF) and Cedars-Sinai Guerin Children's team up to launch new clinic for families living with Angelman syndrome

Retrieved on: 
Tuesday, February 20, 2024

AURORA, Ill., Feb. 20, 2024 /PRNewswire-PRWeb/ -- The Angelman Syndrome Foundation is proud to announce a new collaboration with Cedars-Sinai Guerin Children's to launch a new clinic for patients with Angelman syndrome, a rare neuro-genetic disorder.

Key Points: 
  • The Angelman Syndrome Foundation is proud to announce a new collaboration with Cedars-Sinai Guerin Children's to launch a new clinic for patients with Angelman syndrome, a rare neuro-genetic disorder.
  • AURORA, Ill., Feb. 20, 2024 /PRNewswire-PRWeb/ -- The Angelman Syndrome Foundation is proud to announce a new collaboration with Cedars-Sinai Guerin Children's to launch a new clinic for patients with Angelman syndrome, a rare neuro-genetic disorder.
  • The clinic is led by Cesar Ochoa-Lubinoff, MD, MPH , director of Developmental-Behavioral Pediatrics at Cedars-Sinai Guerin Children's, who previously co-directed the Angelman syndrome clinic at Rush University Medical Center in Chicago.
  • "In my experience, families facing Angelman syndrome are resilient, but they need a supportive medical team in place," Ochoa-Lubinoff said.

Multi Board-Certified Physician Sam Setareh Opens MDVIP-Affiliated Primary Care Practice in Los Angeles

Retrieved on: 
Wednesday, February 14, 2024

LOS ANGELES and BOCA RATON, Fla., Feb. 14, 2024 /PRNewswire/ -- MDVIP, the market leader in personalized healthcare with a network of over 1,100 physicians nationwide, today announced the opening of a new MDVIP-affiliated internal medicine practice in Los Angeles. Sam Setareh, M.D., M.S., F.A.C.C., is currently accepting patients who want a more direct relationship with their primary care physician. Dr. Setareh brings an impressive and diversified background to MDVIP, including four board certifications in Internal Medicine, Cardiovascular Disease, Nuclear Cardiology and Echocardiology, and he is an attending physician at Cedars-Sinai Medical Center in Los Angeles.  Dr. Setareh serves as a member of multiple committees on the American College of Cardiology and the American Heart Association and as a founding member of the editorial board of The Journal of Scientific Innovation in Medicine.

Key Points: 
  • , is currently accepting patients who want a more direct relationship with their primary care physician.
  • Dr. Setareh brings an impressive and diversified background to MDVIP, including four board certifications in Internal Medicine, Cardiovascular Disease, Nuclear Cardiology and Echocardiology, and he is an attending physician at Cedars-Sinai Medical Center in Los Angeles.
  • "As an MDVIP-affiliated primary care physician, my mission is to help empower patients to take better control of their health through preventive medicine and highly individualized care," said Dr. Setareh, who has subspecialties in preventive cardiology, sports cardiology and advanced cardiovascular imaging.
  • He has treated and taken care of patients from all walks of life, including the most vulnerable to heads-of-state, dignitaries, athletes, celebrities and physician colleagues.

The Foundation for the National Institutes of Health Launches First Public-Private Partnership for Early Detection of Preeclampsia

Retrieved on: 
Monday, February 12, 2024

The Foundation for the National Institutes of Health (FNIH) today announces the launch of a new public-private partnership to develop tools to identify pregnant women at high risk of early-onset preeclampsia.

Key Points: 
  • The Foundation for the National Institutes of Health (FNIH) today announces the launch of a new public-private partnership to develop tools to identify pregnant women at high risk of early-onset preeclampsia.
  • Preeclampsia is a serious pregnancy-related hypertensive disorder that can lead to maternal and neonatal deaths and long-term negative health outcomes.
  • The disorder is becoming more prevalent in the United States, with women of color more likely to be affected and experience poor outcomes.
  • Currently, preeclampsia risk is determined early in pregnancy using a combination of maternal medical history and clinical risk factors.

Press Ganey Recognizes its HX24 Executive Award Winners for Leading Industry to Improve the Human Experience in Healthcare

Retrieved on: 
Tuesday, February 6, 2024

Press Ganey , the leader in helping healthcare providers and health plans transform the Human Experience (HX), today announced eight recipients of its HX24 Award at the organization’s annual national client conference.

Key Points: 
  • Press Ganey , the leader in helping healthcare providers and health plans transform the Human Experience (HX), today announced eight recipients of its HX24 Award at the organization’s annual national client conference.
  • This executive award honors one individual who has been an influential leader in their organization and community over the course of their career.
  • HX24 HRO Foundation Award: Northeast Georgia Health System (Gainesville, GA)
    This executive award recognizes an organization who prioritizes safety, quality, and high reliability as a main pillar.
  • HX24 CXO of the Year Award: Sven Gierlinger, Chief Experience Officer, Northwell Health
    This executive award recognizes our roots in Patient Experience and the innovators who are changing PX along with us.

National Academy of Medicine Member New President of The Obesity Society

Retrieved on: 
Thursday, February 1, 2024

ROCKVILLE, Md. , Feb. 1, 2024 /PRNewswire/ -- A member of the National Academy of Medicine is the new president of The Obesity Society (TOS), the organization announced today.

Key Points: 
  • , Feb. 1, 2024 /PRNewswire/ -- A member of the National Academy of Medicine is the new president of The Obesity Society (TOS), the organization announced today.
  • He also co-directs the Atrium Health Wake Forest Baptist Weight Management Center, where he oversees medical weight management programs.
  • "I am honored to serve as president of TOS during such a transformative time in the field of obesity.
  • The Obesity Society (TOS) is the leading organization of scientists and health professionals devoted to understanding and reversing the epidemic of obesity and its adverse health, economic and societal effects.

Los Angeles Vasectomy and Vasectomy Reversal Specialist, Dr. Justin Houman, is Appointed Assistant Professor at Cedars-Sinai Medical Center

Retrieved on: 
Tuesday, January 23, 2024

LOS ANGELES, Jan. 23, 2024 /PRNewswire-PRWeb/ -- As an esteemed assistant professor in urology at Cedars-Sinai Medical Center, Dr. Justin Houman will continue enhancing the quality of life for men by improving their sexual, reproductive and hormonal health. Dr. Houman provides his patients with the latest and most effective treatments available, with extensive expertise in vasectomy, vasectomy reversal, infertility, testosterone, Peyronie's disease, erectile dysfunction and urology. Also, as a top minimally invasive microscopic surgeon, Dr. Houman delivers skill and expertise in microsurgical varicocelectomies, vasectomy reversals, sperm retrievals, penile implants and male incontinence. His vast knowledge and experience in urology have earned him recognition as a leading authority in men's health. Dr. Houman's appointment at Cedars-Sinai Medical Center is a testament to his exceptional skills, dedication and unwavering commitment to patient care. As an assistant professor, Dr. Houman will continue to contribute to the advancement of urological research and education for his patients and students.

Key Points: 
  • Board-certified and fellowship-trained urologist, Dr. Justin Houman, is a top men's health specialist and leading urological surgeon in the Los Angeles area.
  • LOS ANGELES, Jan. 23, 2024 /PRNewswire-PRWeb/ -- As an esteemed assistant professor in urology at Cedars-Sinai Medical Center, Dr. Justin Houman will continue enhancing the quality of life for men by improving their sexual, reproductive and hormonal health.
  • Dr. Houman provides his patients with the latest and most effective treatments available, with extensive expertise in vasectomy, vasectomy reversal , infertility, testosterone, Peyronie's disease, erectile dysfunction and urology.
  • Dr. Houman's appointment at Cedars-Sinai Medical Center is a testament to his exceptional skills, dedication and unwavering commitment to patient care.

Los Angeles Vasectomy and Vasectomy Reversal Specialist, Dr. Justin Houman, Recognized as a 2024 Top Patient Rated Doctor by Find Local Doctors

Retrieved on: 
Monday, January 8, 2024

LOS ANGELES, Jan. 8, 2024 /PRNewswire-PRWeb/ -- Dr. Justin Houman, a highly esteemed board-certified urologist and renowned men's health specialist, has received the Top Patient Rated Doctor award from Find Local Doctors. This recognition is a result of his five-star ratings and exceptional reviews from patients. Find Local Doctors is a trusted online directory that allows patients to locate and connect with the best physicians in their area. Dr. Houman's practice offers a comprehensive approach to men's health, specializing in the diagnosis and treatment of various urological conditions. With his expertise and commitment to patient care, he has become a trusted authority in his field. Dr. Houman's state-of-the-art practice is centered on enhancing his patients' quality of life through comprehensive male urology. He specializes in male fertility, erectile dysfunction, sexual performance, testosterone management and Peyronie's disease. The clinic has been recognized as a Xiaflex Center of Excellence for the treatment of Peyronie's disease. Also, as a top minimally invasive microscopic surgeon, Dr. Houman provides skill and expertise in microsurgical varicocelectomies, vasectomy reversals, sperm retrievals, penile implants and male incontinence.

Key Points: 
  • LOS ANGELES, Jan. 8, 2024 /PRNewswire-PRWeb/ -- Dr. Justin Houman, a highly esteemed board-certified urologist and renowned men's health specialist, has received the Top Patient Rated Doctor award from Find Local Doctors.
  • Find Local Doctors is a trusted online directory that allows patients to locate and connect with the best physicians in their area.
  • Dr. Houman's practice offers a comprehensive approach to men's health, specializing in the diagnosis and treatment of various urological conditions.
  • Dr. Justin Houman's clinic is located at 8635 W 3rd St, Suite 1W in Los Angeles, CA.

ABVC BioPharma Shares Insights from Dr. Scott Irwin of Cedars-Sinai Medical Center over Depression in Cancer Patients Clinical Trials

Retrieved on: 
Tuesday, December 5, 2023

Dr. Irwin serves as the Principal Investigator for the clinical trials of ABV-1601, the Company’s drug under development to treat depression in cancer patients.

Key Points: 
  • Dr. Irwin serves as the Principal Investigator for the clinical trials of ABV-1601, the Company’s drug under development to treat depression in cancer patients.
  • “Dr.
  • Irwin is trustworthy, sincere, devoted to the work, and takes things that concern his patients seriously.
  • We are grateful for him joining our study as the principal investigator,” said Uttam Patil, Ph.D., Chief Executive Officer of ABVC .

Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with US HUPO Computational Proteomics Award

Retrieved on: 
Thursday, November 30, 2023

The award recognizes Dr. Mallick’s career achievements and contributions to bioinformatics analyses and computational methods widely used by the proteomics community.

Key Points: 
  • The award recognizes Dr. Mallick’s career achievements and contributions to bioinformatics analyses and computational methods widely used by the proteomics community.
  • “Developments in computational proteomics enable researchers globally to advance biomedicine,” said Dr. Mallick.
  • “I am extremely grateful to receive the Computational Proteomics Award from US HUPO.
  • “Working side-by-side with Parag since we founded Nautilus, I’ve witnessed firsthand his incredible personal commitment and contributions to computational proteomics,” said Sujal Patel, CEO of Nautilus.